Debt

Bank Line of Credit and Term Loans

The Company’s $2.0 billion unsecured revolving line of credit facility (the “Facility”) matures on March 31, 2018 and contains a committed one-year extension option, at a cost of 30 basis points. Borrowings under the Facility accrue interest at LIBOR plus a margin that depends on the Company’s credit ratings. The Company pays a facility fee on the entire revolving commitment that depends on its credit ratings. Based on the Company’s credit ratings at June 30, 2017, the margin on the Facility was 1.05% and the facility fee was 0.20%. The Facility also includes a feature that allows the Company to increase the borrowing capacity by an aggregate amount of up to $500 million, subject to securing additional commitments from existing lenders or new lending institutions. During the six months ended June 30, 2017, the Company had net repayments of $781 million primarily using proceeds from the RIDEA II joint venture disposition, the sale of its Four Seasons Notes and the repayment of its HC-One Facility. At June 30, 2017, the Company had £105 million ($136 million) outstanding under the Facility with a weighted average effective interest rate of 1.63%.

On July 30, 2012, the Company entered into a credit agreement with a syndicate of banks for a £137 million unsecured term loan (the “2012 Term Loan”). In March 2017, the Company repaid the 2012 Term Loan.

On June 30, 2017, the Company repaid £51 million of its four-year unsecured term loan entered into in January 2015 (the "2015 Term Loan"). Concurrently, the Company terminated its three-year interest rate swap which fixed the interest of the 2015 Term Loan. Effective June 30, 2017, the 2015 Term Loan accrues interest at a rate of GBP LIBOR plus 1.15%, subject to adjustments based on the Company's credit ratings. At June 30, 2017 the Company had £169 million ($219 million) outstanding on the 2015 Term Loan.

The Facility and 2015 Term Loan contain certain financial restrictions and other customary requirements, including cross-default provisions to other indebtedness. Among other things, these covenants, using terms defined in the agreements: (i) limit the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value to 60%; (ii) limit the ratio of Secured Debt to Consolidated Total Asset Value to 30%; (iii) limit the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value to 60%; and (iv) require a minimum Fixed Charge Coverage ratio of 1.5 times. The Facility and Term Loan also require a Minimum Consolidated Tangible Net Worth of $6.5 billion at June 30, 2017. At June 30, 2017, the Company was in compliance with each of these restrictions and requirements of the Facility and Term Loan.

Senior Unsecured Notes

At June 30, 2017, the Company had senior unsecured notes outstanding with an aggregate principal balance of $7.0 billion. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions and other customary terms. The Company believes it was in compliance with these covenants at June 30, 2017.

The following table summarizes the Company’s senior unsecured notes payoffs for the year ended December 31, 2016 (dollars in thousands):



Date	Amount		Coupon Rate
February 1, 2016	$	500,000	3.750	%
September 15, 2016	$	400,000	6.300	%
November 30, 2016	$	500,000	6.000	%
November 30, 2016	$	600,000	6.700	%

The following table summarizes the Company's senior unsecured note payoffs for the six months ended June 30, 2017 (dollars in thousands):



Date	Amount		Coupon Rate
May 1, 2017	$	250,000	5.625	%

There were no senior unsecured notes issuances for the six months ended June 30, 2017 and the year ended December 31, 2016.

Mortgage Debt

At June 30, 2017, the Company had $140 million in aggregate principal of mortgage debt outstanding, which is secured by 16 healthcare facilities (including redevelopment properties) with a carrying value of $306 million. In March 2017, the Company paid off $472 million of mortgage debt.

Debt Maturities

The following table summarizes the Company’s stated debt maturities and scheduled principal repayments at June 30, 2017 (in thousands):



Year	Bank Line of Credit⁽¹⁾		2015 Term Loan⁽²⁾			Senior Unsecured Notes⁽³⁾			Mortgage Debt⁽⁴⁾		Total⁽⁵⁾
2017 (six months)	$	—	$	—		$	—		$	1,685	$	1,685
2018	136,311		—			—			3,512		139,823
2019	—		219,396			450,000			3,700		673,096
2020	—		—			800,000			3,758		803,758
2021	—		—			1,200,000			11,117		1,211,117
Thereafter	—		—			4,500,000			116,481		4,616,481
	136,311		219,396			6,950,000			140,253		7,445,960
(Discounts), premium and debt costs, net	—		(564		)	(60,955		)	6,084		(55,435		)
	$	136,311	$	218,832		$	6,889,045		$	146,337	$	7,390,525

_______________________________________


(1)	Represents £105 million translated into U.S. dollars (“USD”).


(2)	Represents £169 million translated into USD.


(3)	Effective interest rates on the notes ranged from 2.79% to 6.88% with a weighted average effective interest rate of 4.29% and a weighted average maturity of six years.


(4)	Interest rates on the mortgage debt ranged from 2.99% to 5.91% with a weighted average effective interest rate of 4.23% and a weighted average maturity of twenty years.


(5)	Excludes $95 million of other debt that have no scheduled maturities.

Subsequent Event

In July 2017, the Company repurchased $500 million of its 5.375% senior notes due 2021 and expects to record approximately $54 million of loss on debt extinguishment in the third quarter of 2017.